Trials / Conditions / Recurrent or Metastatic Breast Cancer
Recurrent or Metastatic Breast Cancer
5 registered clinical trials studyying Recurrent or Metastatic Breast Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Phase III Study of SYS6010 Versus Chemotherapy in HER2-Negative, EGFR-Positive Recurrent or Metastatic Breas NCT07406542 | CSPC Megalith Biopharmaceutical Co.,Ltd. | Phase 3 |
| Unknown | Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer NCT03947736 | Chinese Academy of Medical Sciences | — |
| Completed | Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer NCT03326102 | Daehwa Pharmaceutical Co., Ltd. | Phase 2 |
| Active Not Recruiting | Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy NCT03315364 | Daehwa Pharmaceutical Co., Ltd. | Phase 2 / Phase 3 |
| Completed | Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast C NCT03109249 | Sun Pharma Advanced Research Company Limited | Phase 1 |